Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lascoux

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Presse Medicale (Paris, France : 1983)|March 2, 1996
[Non-nucleoside antiretroviral agents]D Sereni, C Lascoux, V Gomez
Journal of Animal Science|February 23, 2018
Comparison of 3 methods for estimating enteric methane and carbon dioxide emission in nonlactating cowsM Doreau, M Arbre, Y Rochette, et al.
HIV Medicine|March 12, 2004
Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial)J-M Molina, G Peytavin, S Perusat, et al.
Journal of Medicine and Life|July 18, 2012
Acute microbiologically negative hypoxic interstitial pneumonia on HAART: Immune Reconstitution Inflammatory Syndrome unmasking Pneumocystis jiroveci infection with an atypical presentationS Sovaila, A de Raigniac, C Picard, et al.
La Revue De Medecine Interne|March 10, 2009
[From retroperitoneal fibrosis to gastric linitis]L Amrouche, J-M Gornet, C Lascoux, et al.
Drug and Alcohol Dependence|January 18, 2011
Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physicianP Roux, J Cohen, C Lascoux-Combe, et al.
Vaccine|September 17, 2011
Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccinationM Winnock, F Bani-Sadr, E Pambrun, et al.
The Journal of Investigative Dermatology|October 26, 2001
Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapyC Pellet, S Chevret, L Blum, et al.
Journal of Viral Hepatitis|August 18, 2009
Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virusA Boyd, K Lacombe, P Miailhes, et al.
Journal of Clinical Pathology|January 8, 2009
Histological scoring of fibrosis and activity in HIV-chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slidesD Wendum, K Lacombe, M Chevallier, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Presse Medicale (Paris, France : 1983)|March 2, 1996
[Non-nucleoside antiretroviral agents]D Sereni, C Lascoux, V Gomez
Journal of Animal Science|February 23, 2018
Comparison of 3 methods for estimating enteric methane and carbon dioxide emission in nonlactating cowsM Doreau, M Arbre, Y Rochette, et al.
HIV Medicine|March 12, 2004
Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial)J-M Molina, G Peytavin, S Perusat, et al.
Journal of Medicine and Life|July 18, 2012
Acute microbiologically negative hypoxic interstitial pneumonia on HAART: Immune Reconstitution Inflammatory Syndrome unmasking Pneumocystis jiroveci infection with an atypical presentationS Sovaila, A de Raigniac, C Picard, et al.
La Revue De Medecine Interne|March 10, 2009
[From retroperitoneal fibrosis to gastric linitis]L Amrouche, J-M Gornet, C Lascoux, et al.
Drug and Alcohol Dependence|January 18, 2011
Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physicianP Roux, J Cohen, C Lascoux-Combe, et al.
Vaccine|September 17, 2011
Prevalence of immunity to hepatitis viruses A and B in a large cohort of HIV/HCV-coinfected patients, and factors associated with HAV and HBV vaccinationM Winnock, F Bani-Sadr, E Pambrun, et al.
The Journal of Investigative Dermatology|October 26, 2001
Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapyC Pellet, S Chevret, L Blum, et al.
Journal of Viral Hepatitis|August 18, 2009
Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virusA Boyd, K Lacombe, P Miailhes, et al.
Journal of Clinical Pathology|January 8, 2009
Histological scoring of fibrosis and activity in HIV-chronic hepatitis B related liver disease: performance of the METAVIR score assessed on virtual slidesD Wendum, K Lacombe, M Chevallier, et al.
Pageof 2